While epigenetic therapies such as for example histone deacetylase inhibitors (HDACi) have previously been evaluated in FL, outcomes were general predated and disappointing our current understanding of the epigenomic surroundings of the malignancy?[29], which might give a rationale to steer relating to patients underlying (epi)genetic profiles therapy

While epigenetic therapies such as for example histone deacetylase inhibitors (HDACi) have previously been evaluated in FL, outcomes were general […]